• BIOMEDICAL RESEARCH
• MAGNETIC RESONANCE IMAGING
• MARINE BIODIVERSITY
• MICROBIOLOGY
• MOLECULAR MODELING
• NATURAL PRODUCTS CHEMISTRY
• NEUROTOXINS
• NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
• PHARMACOGNOSY
• PHARMACOLOGY
• POISONOUS MARINE LIFE

Dr. Mark T. Hamann, Ph.D. is a natural products chemist with over 20 years of pharmaceutical industry and academic research experience in the field of marine natural products chemistry and drug development. Dr. Hamann completed his Ph.D. in Organic Chemistry in 1992 at the University of Hawaii, Honolulu, HI, in the laboratory of the late Professor Paul J. Scheuer. Dr. Hamann holds joint faculty positions in the Departments of Pharmacology, Chemistry and Biochemistry, Pharmacy Practice as well as the National Center for Natural Products Research and also serves as an Adjunct Professor at the Center for Marine Biotechnology, University of Mississippi. His research group at the University of Mississippi, Department of Pharmacognosy & Pharmacology, is focused on the characterization of prototype drug-leads from chemically defended marine organisms. Dr. Hamann has served as the primary investigator on more than 10 research projects over the past ten years totaling over $6 million in funded research support in addition to directing the chemistry core of the NIH funded ($11 million) Center for Neuropharmacology. Dr. Hamann's research programs have also been funded by: The World Health Organization, Medicines for Malaria Venture (Gates Foundation), Monsanto Corporate Research, Chiron Pharmaceuticals, Novartis Pharmaceuticals, PharmaMar (Zeltia), Kraft Foods, The Environmental Protection Agency (EPA), NASA, the National SeaGrant Programs (NOAA) and a variety of International Visiting Scholar Programs.